帕金森病患者的鼓舞性肌肉训练:混合方法随机对照试验的协议
Juliana Fernandes Barreto de Mendonca1, Elisabeth Preston2, Allyson Flynn2
1Discipline of Physiotherapy, Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia julianafbmau@gmail.com.
BMJ open respiratory research
|June 23, 2025
概括
这项研究调查了帕金森病患者呼吸短促的启发性肌肉训练. 这项研究旨在确定这种训练是否能改善呼吸力,呼吸和整体生活质量.
科学领域:
- 神经学 神经学
- 呼吸系统医学 呼吸系统医学
- 康复 康复 康复 康复
背景情况:
- 在帕金森病 (PD) 中,鼓舞性肌肉衰弱很常见,可能导致呼吸不良.
- 鼓舞性肌肉训练 (IMT) 有效治疗其他慢性疾病中的呼吸障碍.
- IMT对PD患者的影响仍未得到充分研究.
研究的目的:
- 评估一项为期8周的IMT计划对PD患者呼吸肌肉强度的影响.
- 评估IMT对PD患者呼吸障碍,运动功能,运动能力和生活质量的影响.
- 通过定性采访,探索参与者与IMT的经验.
主要方法:
- 一个混合方法,随机对照试验,涉及50名患有特异性PD的参与者.
- 参与者被分配到一个为期8周的IMT或对照组.
- 主要结果:最大的吸入压力. 二次结果:MDS-UPDRS第二部分,博格尺度,6分钟步行测试,PDQ-39. 从采访中获得的定性数据,使用专题分析进行分析.
主要成果:
- 将分析最大吸气压的初级结果数据.
- 将分析关于运动体验,感知劳动力,运动能力和生活质量的二次结果数据.
- 定性数据将探索参与者与IMT的实践经验.
结论:
- 这项研究将为IMT在控制呼吸系统症状和改善帕金森病患者生活质量的有效性提供关键的见解.
- 结果将为临床实践和未来的研究方向提供信息,用于PD的非药物干预.
- 混合方法方法将全面了解IMT的好处和患者的观点.
更多相关视频
相关概念视频
Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391
Parkinson's Disease: Overview
722
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
722


